Skip to main content

Hypoxia-related biomarkers in HER2 + breast cancer cell lines for the development of personalised therapy

Project/agreement No.
13150102
Project funding
20 000.00 EUR
Project realization
01.07.2020. - 30.06.2021.

Aim

The aim of the project is to identify potential acute hypoxia-related biomarkers and therapy targets by conducting large-scale bioinformatics data analysis in the publicly available Metabric database of breast cancer multi-omics files and to verify them experimentally in HER2+ breast cancer reference cell lines.